Conversion of stationary to invasive tumor initiating cells (TICs): Role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Li, Jian ^a   Zucker, Stanley ^b   Pulkoski Gross, Ashleigh ^a   Kuscu, Cem ^a   Karaayvaz, Mihriban ^a   Ju, Jingfang ^a   Yao, Herui ^c   Song, Erwei ^c   Cao, Jian ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Veterans Affair Medical Center   (United States)

^c SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; HERMES ANTIGEN; HOX PROTEIN; MATRIX METALLOPROTEINASE 14; MICRORNA 10B; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR HOXD10; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INVASION; CELL HYPOXIA; CELL INVASION; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR CELL; TUMOR INITIATING CELL; UPREGULATION; BREAST TUMOR; FLOW CYTOMETRY; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; FLOW CYTOMETRY; HUMANS; MATRIX METALLOPROTEINASE 14; PROTEIN TRANSPORT; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84861898056     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038403     Document Type: Article

References (52)

1. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, et al. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323.
2. Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, et al. (2011) Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 29: 32-45.
3. Pang R, Law WL, Chu AC, Poon JT, Lam CS, et al. (2010) A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 6: 603-615.
4. Bonnet D, Dick JE, (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737.
5. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, et al. (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511.
6. Hill RP, (2006) Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66: 1891-1895; discussion 1890.
7. Balic M, Lin H, Young L, Hawes D, Giuliano A, et al. (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12: 5615-5621.
8. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T, (2005) Opinion: migrating cancer stem cells- an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749.
9. Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, et al. (2009) Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28: 3949-3959.
10. Koshikawa N, Maejima C, Miyazaki K, Nakagawara A, Takenaga K, (2006) Hypoxia selects for high-metastatic Lewis lung carcinoma cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors. Oncogene 25: 917-928.
11. Kessenbrock K, Plaks V, Werb Z, (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
12. Cao J, Kozarekar P, Pavlaki M, Chiarelli C, Bahou WF, et al. (2004) Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration. JBiolChem 279: 14129-14139.
13. Cao J, Chiarelli C, Richman O, Zarrabi K, Kozarekar P, et al. (2008) Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer. JBiolChem 283: 6232-6240.
14. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123.
15. Vaupel P, Kelleher DK, Hockel M, (2001) Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 28: 29-35.
16. Koga F, Tsutsumi S, Neckers LM, (2007) Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells. Cell Cycle 6: 1393-1402.
17. Moon EJ, Brizel DM, Chi JT, Dewhirst MW, (2007) The potential role of intrinsic hypoxia markers as prognostic variables in cancer. Antioxid Redox Signal 9: 1237-1294.
18. Sabeh F, Li XY, Saunders TL, Rowe RG, Weiss SJ, (2009) Secreted versus membrane-anchored collagenases: relative roles in fibroblast-dependent collagenolysis and invasion. J Biol Chem 284: 23001-23011.
19. Tomari T, Koshikawa N, Uematsu T, Shinkawa T, Hoshino D, et al. (2009) High throughput analysis of proteins associating with a proinvasive MT1-MMP in human malignant melanoma A375 cells. Cancer Sci 100: 1284-1290.
20. Toth M, Osenkowski P, Hesek D, Brown S, Meroueh S, et al. (2005) Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase. Biochem J 387: 497-506.
21. Cao J, Sato H, Takino T, Seiki M, (1995) The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 270: 801-805.
22. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
23. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
24. Guo Y, Ma J, Wang J, Che X, Narula J, et al. (1994) Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 54: 1561-1565.
25. Dougherty GJ, Cooper DL, Memory JF, Chiu RK, (1994) Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1. J Biol Chem 269: 9074-9078.
26. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, et al. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89.
27. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
28. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
29. Zucker S, Hymowitz M, Conner CE, DiYanni EA, Cao J, (2002) Rapid trafficking of membrane type 1-matrix metalloproteinase to the cell surface regulates progelatinase a activation. Lab Invest 82: 1673-1684.
30. Ma L, Teruya-Feldstein J, Weinberg RA, (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
31. Myers C, Charboneau A, Cheung I, Hanks D, Boudreau N, (2002) Sustained expression of homeobox D10 inhibits angiogenesis. Am J Pathol 161: 2099-2109.
32. Carrio M, Arderiu G, Myers C, Boudreau NJ, (2005) Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res 65: 7177-7185.
33. Lu X, Kang Y, (2010) Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 16: 5928-5935.
34. Yoon SO, Shin S, Mercurio AM, (2005) Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the alpha6beta4 integrin. Cancer Res 65: 2761-2769.
35. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
36. Sabeh F, Shimizu-Hirota R, Weiss SJ, (2009) Protease-dependent versus-independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol 185: 11-19.
37. Zucker S, Pei D, Cao J, Lopez-Otin C, (2003) Membrane type-matrix metalloproteinases (MT-MMP). CurrTopDevBiol 54: 1-74.
38. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, et al. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
39. Mayer G, Boileau G, Bendayan M, (2003) Furin interacts with proMT1-MMP and integrin alphaV at specialized domains of renal cell plasma membrane. J Cell Sci 116: 1763-1773.
40. Miyoshi A, Kitajima Y, Ide T, Ohtaka K, Nagasawa H, et al. (2006) Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner. Int J Oncol 29: 1533-1539.
41. Noda K, Ishida S, Shinoda H, Koto T, Aoki T, et al. (2005) Hypoxia induces the expression of membrane-type 1 matrix metalloproteinase in retinal glial cells. Invest Ophthalmol Vis Sci 46: 3817-3824.
42. Munoz-Najar UM, Neurath KM, Vumbaca F, Claffey KP, (2006) Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 25: 2379-2392.
43. Bravo-Cordero JJ, Marrero-Diaz R, Megias D, Genis L, Garcia-Grande A, et al. (2007) MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. EMBO J 26: 1499-1510.
44. Steffen A, Le Dez G, Poincloux R, Recchi C, Nassoy P, et al. (2008) MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7. Curr Biol 18: 926-931.
45. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL, (2008) CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 98: 756-765.
46. Han JS, Crowe DL, (2009) Tumor initiating cancer stem cells from human breast cancer cell lines. Int J Oncol 34: 1449-1453.
47. Martin MD, Kremers GJ, Short KW, Rocheleau JV, Xu L, et al. (2010) Rapid Extravasation and Establishment of Breast Cancer Micrometastases in the Liver Microenvironment. Mol Cancer Res.
48. Biddle A, Liang X, Gammon L, Fazil B, Harper LJ, et al. (2011) Cancer Stem Cells in Squamous Cell Carcinoma Switch between Two Distinct Phenotypes That Are Preferentially Migratory or Proliferative. Cancer Res 71: 5317-5326.
49. Chen CZ, Li L, Lodish HF, Bartel DP, (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
50. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256.
51. Cao J, Drews M, Lee HM, Conner C, Bahou WF, et al. (1998) The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A. JBiolChem 273: 34745-34752.
52. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, et al. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270.